Specifically, epigenetic loss of Protein phosphatase 2, regulatory subunit B, beta (PPP2R2B), occurring in >90% colorectal tumor samples, was indicated as a molecular event affecting the sensitivity of CRC to mTOR inhibitors [164]. Here, PPP2R2B is linked to colorectal neoplasm.